Skip to main content
Clinical Trials/NL-OMON36504
NL-OMON36504
Not yet recruiting
Not Applicable

EXIST: Physical exercise to improve fitness and combat fatigue in patients with Multiple Myeloma or (non-) Hodgkin*s lymphoma after high dose chemotherapy and autologous stem cell transplantation. - EXIST

Academisch Medisch Centrum0 sites125 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Academisch Medisch Centrum
Enrollment
125
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \-diagnosed with multiple myeloma in first line or or with HL/NHL in first line or first relapse, who have undergone HDC and autologous SCT 6 to 12 weeks ago or who where recently (\< 8 months) treated with HDC and autologous SCT and who have completed radiotherapy or their last cycle of consolidation chemotherapy 2 to 6 weeks ago\-Sufficiently recovered from the SCT and having peripheral blood recovery;
  • \-Age between 18 and 65 years;
  • \-Ability to cycle on a bicycle ergometer against a load of at least 25 Watt;
  • \-Ability to walk at least 100 meters independently without crutches/cains or walking frame;
  • \-Written informed consent.

Exclusion Criteria

  • \-tandem autologous\-allogeneic stem cell transplantation
  • \-Severe cognitive impairment;
  • \-Severe emotional instability;
  • \-Insufficient mastery of the Dutch language;
  • \-Presence of extensive osteolytic lesions with risk of fracture;
  • \-Serious cardiopulmonary and cardiovascular conditions;
  • \-Other disabling comorbidity interfering with the intervention program or influencing outcome parameters (a.o. having a pacemaker , epileptic seizures and poorly regulated diabetes mellitus);
  • \-Severe infections;
  • \-Relapse/progression of disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials